The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1972, 108: 1631-1636.
Copyright © 1972 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomana, M.
Right arrow Articles by Niedermeier, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tomana, M.
Right arrow Articles by Niedermeier, W.

Studies on Human Secretory Immunoglobulin A.

IV. Carbohydrate Composition1

Milan Tomana, Jiri Mestecky and William Niedermeier

From the Division of Clinical Immunology and Rheumatology and the Institute of Dental Research, University of Alabama in Birmingham, Alabama 35233

Abstract

Human secretory IgA (S-IgA) from colostrum contains 8.7% carbohydrate consisting of 0.7% fucose, 2.6% mannose, 1.6% galactose, 2.5% glucosamine, 0.2% galactosamine, and 1.1% sialic acid. The carbohydrate content is unevenly distributed among the polypeptide chains. Assuming that the S-IgA is composed of four heavy (H) chains, four light (L) chains, one secretory component (SC) and one J chain, the total carbohydrate content would be distributed as follows: 63% in H chains, 28% in SC, 6.5% in J chain, and 2.5% in L chains.

The qualitative composition and the ratio between individual carbohydrates is similar in the different types of polypeptide chains, with the two following exceptions: galactosamine was found only in H chains and a higher content of fucose was detected in SC than in the rest of the chains.

Footnotes

1 This investigation was supported by Grants AM 03555-12 from the National Institute of Arthritis and Metabolic Diseases and DE 02670-05 from the National Institute of Dental Research.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
L. J. Marshall, B. Perks, K. Bodey, R. Suri, A. Bush, and J. K. Shute
Free Secretory Component from Cystic Fibrosis Sputa Displays the Cystic Fibrosis Glycosylation Phenotype
Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Schroten, C. Stapper, R. Plogmann, H. Kohler, J. Hacker, and F.-G. Hanisch
Fab-Independent Antiadhesion Effects of Secretory Immunoglobulin A on S-Fimbriated Escherichia coli Are Mediated by Sialyloligosaccharides
Infect. Immun., August 1, 1998; 66(8): 3971 - 3973.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.